| CTRI Number |
CTRI/2026/01/102620 [Registered on: 30/01/2026] Trial Registered Prospectively |
| Last Modified On: |
01/07/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Behavioral |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Solution focused group therapy for improving resilience, self efficacy, coping and growth mindset in adolescents with adverse childhood experiences |
|
Scientific Title of Study
|
Development and Evaluation of Solution Focused Group Intervention Module for Adolecents with Adverse Childhood Experiences. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Neethumol Xaviour |
| Designation |
Research Scholar |
| Affiliation |
Institute of Mental Health and Neurosciences |
| Address |
Department of Psychiatric Social Work
Institute of Mental Health and Neurosciences Kozhikode
Kozhikode
KERALA
673008
India |
| Phone |
7034056654 |
| Fax |
|
| Email |
neethu@imhans.ac.in |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr. Seema P Uthaman |
| Designation |
Asst Professor and Head |
| Affiliation |
Institute of Mental Health and Neurosciences |
| Address |
Department of Psychiatric Social Work
Institute of Mental Health and Neurosciences Kozhikode
Kozhikode
KERALA
673008
India |
| Phone |
9074277506 |
| Fax |
|
| Email |
seema@imhans.ac.in |
|
Details of Contact Person
Public Query
|
| Name |
Neethumol Xaviour |
| Designation |
Research Scholar |
| Affiliation |
Institute of Mental Health and Neurosciences |
| Address |
Department of Psychiatric Social Work
Institute of Mental Health and Neurosciences Kozhikode
Kozhikode
KERALA
673008
India |
| Phone |
7034056654 |
| Fax |
|
| Email |
neethu@imhans.ac.in |
|
|
Source of Monetary or Material Support
|
| European Brief Therapy Assosciation (EBTA )The office of EBTA, 3Grand Rue,69001,Lyon, France |
|
|
Primary Sponsor
|
| Name |
European Brief Therapy Assosciation EBTA |
| Address |
The office of EBTA, 3Grand Rue,69001,Lyon, France |
| Type of Sponsor |
Other [EBTA is a nonprofit civil society organization] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Seema P Uthaman |
Institute of Mental Health and Neurosciences |
Division of Psychiatric Social Work, Department of PSW, Room No. 110
Kozhikode
KERALA |
0495 235 9352
Seema@imhans.ac.in |
|
|
Details of Ethics Committee
|
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: G||Mental Health, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Not Applicable |
Not applicable |
| Intervention |
Solution focused group intervention |
The intervention will be delivered once weekly, with each session lasting 90 minutes, over a total duration of 5 weeks. |
|
|
Inclusion Criteria
|
| Age From |
15.00 Year(s) |
| Age To |
18.00 Year(s) |
| Gender |
Both |
| Details |
Have experienced at least one adverse childhood experience (ACE) as defined by the
ACE study
First-time consultation at the institutes child and adolescent psychiatry outpatient
settings |
|
| ExclusionCriteria |
| Details |
Diagnosed with severe psychiatric disorders that require immediate and intensive
treatment ( psychosis severe autism spectrum disorder ID).
Currently receiving other forms of psychotherapy or counselling that could interfere
with the study’s intervention. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Enhancing the coping strategies, growth mindset,
self-efficacy and resilience of adolescents with adverse childhood experiences. |
Assessments will be conducted at baseline, 5 weeks(post-intervention), and at 3- and 6-month follow-up |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="30"
Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
08/02/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="0"
Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
The study has completed its Phase 1 development of the module, which followed a systematic multiphase process involving a comprehensive literature review and expert interviews. The newly developed module has been validated by the subject experts from the field. Recruitment done. 30 participants selected for the study. Pre-assessment done. 5 sessions of group intervention done and post test done. waiting for the follow up assesment. |